IMCR
IMCR
US45258D1054
Immunocore Holdings plc
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 400.016.000 310.202.000
29.0%
Cost of Revenue 5.087.000 2.731.000
86.3%
Gross Profit 394.929.000 307.471.000
28.4%
440.282.000 377.932.000
16.5%
Operating Income -45.353.000 -70.461.000
35.6%
Pretax Income -19.100.000 -52.937.000
63.9%
Net Income Common Stockholders -35.514.000 -51.087.000
30.5%
-- --
--
-- --
--
ende